Q32 Bio Inc.

NASDAQ (USD): Q32 Bio Inc. (QTTB)

Last Price

3.16

Today's Change

-0.01 (0.31%)

Day's Change

3.08 - 3.21

Trading Volume

91,599

Overview

Market Cap

38 Million

Shares Outstanding

12 Million

Avg Volume

382,138

Avg Price (50 Days)

8.64

Avg Price (200 Days)

28.09

PE Ratio

-0.70

EPS

-4.50

Earnings Announcement

11-Mar-2025

Previous Close

3.16

Open

3.16

Day's Range

3.08 - 3.21

Year Range

2.9 - 53.79

Trading Volume

91,599

Price Change Highlight

1 Day Change

-0.32%

5 Day Change

-3.66%

1 Month Change

-10.48%

3 Month Change

-93.34%

6 Month Change

-92.12%

Ytd Change

-8.41%

1 Year Change

-75.29%

3 Year Change

-95.71%

5 Year Change

-98.99%

10 Year Change

-99.06%

Max Change

-99.06%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment